The present invention relates to fibrous structures and more particularly to fibrous structures that exhibit a pore volume distribution such that greater than about 40% of the total pore volume present in the fibrous structure exists in pores of radii of from about 121 μm to about 200 μm, and to methods for making such fibrous structures.
Consumers of fibrous structures, especially paper towels, require absorbency properties (such as absorption capacity and/or rate of absorption) in their fibrous structures. The pore volume distribution present in the fibrous structures impacts the absorbency properties of the fibrous structures. In the past, some fibrous structures exhibit pore volume distributions that optimize the absorption capacity others exhibit pore volume distributions that optimize the rate of absorption. To date, no known fibrous structures balance the properties of absorption capacity with rate of absorption via the pore volume distribution exhibited by the fibrous structures.
Known fibrous structures exhibit various pore volume distributions. For example, a currently marketed wood pulp-based paper towel exhibits a substantially uniform pore volume distribution. In another example, a currently marketed wipe product has significantly more than 55% of its total pore volume present in the wipe product that exists in pores of radii of less than 100 μm. In yet another example, a currently marketed non-textile washcloth has significantly more than 55% of its total pore volume present in the wipe product that exists in pores of radii of greater than 200 μm.
The problem faced by formulators is how to produce fibrous structures that have a pore volume distribution that balances the absorbency properties (i.e., absorption capacity and rate of absorption) that satisfies the consumers' needs.
Accordingly, there is a need for fibrous structures that exhibit a pore volume distribution such that greater than about 40% and/or greater than about 45% and/or greater than about 50% and/or greater than about 55% and/or greater than about 60% and/or greater than about 75% of the total pore volume present in the fibrous structures exists in pores of radii of from about 121 μm to about 200 μm, and for methods for making such fibrous structures.
The present invention solves the problem identified above by fulfilling the needs of the consumers by providing fibrous structures that exhibit a novel pore volume distribution and methods for making such fibrous structures.
In one example of the present invention, a fibrous structure that exhibits a pore volume distribution such that greater than about 40% and/or greater than about 45% and/or greater than about 50% and/or greater than about 55% and/or greater than about 60% and/or greater than about 75% of the total pore volume present in the fibrous structures exists in pores of radii of from about 121 μm to about 200 μm and/or from about 121 μm to about 180 μm and/or from about 121 μm to about 160 μm as determined by the Pore Volume Distribution Test Method described herein, is provided.
In another example of the present invention, a fibrous structure that exhibits a pore volume distribution such that greater than about 50% and/or greater than about 55% and/or greater than about 60% and/or greater than about 75% of the total pore volume present in the fibrous structures exists in pores of radii of from about 101 μm to about 200 μm and/or from about 101 μm to about 180 μm and/or from about 101 μm to about 160 μm as determined by the Pore Volume Distribution Test Method described herein, is provided.
In yet another example of the present invention, a fibrous structure that exhibits a pore volume distribution such that greater than about 40% and/or greater than about 45% and/or greater than about 50% and/or greater than about 55% and/or greater than about 60% and/or greater than about 75% of the total pore volume present in the fibrous structures exists in pores of radii of from about 121 μm to about 200 μm as determined by the Pore Volume Distribution Test Method described herein and exhibits a pore volume distribution such that greater than about 50% and/or greater than about 55% and/or greater than about 60% and/or greater than about 75% of the total pore volume present in the fibrous structures exists in pores of radii of from about 101 μm to about 200 μm as determined by the Pore Volume Distribution Test Method described herein, is provided.
In even another example of the present invention, a fibrous structure comprising a plurality of filaments wherein the fibrous structure exhibits a pore volume distribution such that greater than about 50% and/or greater than about 55% and/or greater than about 60% and/or greater than about 75% of the total pore volume present in the fibrous structure exists in pores of radii of from about 101 μm to about 200 μm as determined by the Pore Volume Distribution Test Method, is provided.
In still another example of the present invention, a method for making a fibrous structure, the method comprising the step of combining a plurality of filaments and/or solid additives to form a fibrous structure that exhibits a pore volume distribution such that greater than about 40% and/or greater than about 45% and/or greater than about 50% and/or greater than about 55% and/or greater than about 60% and/or greater than about 75% of the total pore volume present in the fibrous structure exists in pores of radii of from about 121 μm to about 200 μm as determined by the Pore Volume Distribution Test Method, is provided.
In even still another example of the present invention, a method for making a fibrous structure, the method comprising the step of combining a plurality of filaments to form a fibrous structure that exhibits a pore volume distribution such that greater than about 50% and/or greater than about 55% and/or greater than about 60% and/or greater than about 75% of the total pore volume present in the fibrous structure exists in pores of radii of from about 101 μm to about 200 μm as determined by the Pore Volume Distribution Test Method, is provided.
In yet another example of the present invention, a sanitary tissue product comprising a fibrous structure according to the present invention is provided.
Accordingly, the present invention provides fibrous structures that solve the problems described above by providing fibrous structures that exhibit a pore volume distribution such that greater than about 40% of the total pore volume present in the fibrous structure exists in pores of radii of from about 121 μm to about 200 μm, and to methods for making such fibrous structures.
Definitions
“Fibrous structure” as used herein means a structure that comprises one or more filaments and/or fibers. In one example, a fibrous structure according to the present invention means an orderly arrangement of filaments and/or fibers within a structure in order to perform a function. Nonlimiting examples of fibrous structures of the present invention include paper, fabrics (including woven, knitted, and non-woven), and absorbent pads (for example for diapers or feminine hygiene products).
Nonlimiting examples of processes for making fibrous structures include known wet-laid papermaking processes and air-laid papermaking processes. Such processes typically include steps of preparing a fiber composition in the form of a suspension in a medium, either wet, more specifically aqueous medium, or dry, more specifically gaseous, i.e. with air as medium. The aqueous medium used for wet-laid processes is oftentimes referred to as a fiber slurry. The fibrous slurry is then used to deposit a plurality of fibers onto a forming wire or belt such that an embryonic fibrous structure is formed, after which drying and/or bonding the fibers together results in a fibrous structure. Further processing the fibrous structure may be carried out such that a finished fibrous structure is formed. For example, in typical papermaking processes, the finished fibrous structure is the fibrous structure that is wound on the reel at the end of papermaking, and may subsequently be converted into a finished product, e.g. a sanitary tissue product.
The fibrous structures of the present invention may be homogeneous or may be layered. If layered, the fibrous structures may comprise at least two and/or at least three and/or at least four and/or at least five layers.
The fibrous structures of the present invention may be co-formed fibrous structures. “Co-formed fibrous structure” as used herein means that the fibrous structure comprises a mixture of at least two different materials wherein at least one of the materials comprises a filament, such as a polypropylene filament, and at least one other material, different from the first material, comprises a solid additive, such as a fiber and/or a particulate. In one example, a co-formed fibrous structure comprises solid additives, such as fibers, such as wood pulp fibers, and filaments, such as polypropylene filaments.
“Solid additive” as used herein means a fiber and/or a particulate.
“Particulate” as used herein means a granular substance or powder.
“Fiber” and/or “Filament” as used herein means an elongate particulate having an apparent length greatly exceeding its apparent width, i.e. a length to diameter ratio of at least about 10. For purposes of the present invention, a “fiber” is an elongate particulate as described above that exhibits a length of less than 5.08 cm (2 in.) and a “filament” is an elongate particulate as described above that exhibits a length of greater than or equal to 5.08 cm (2 in.).
Fibers are typically considered discontinuous in nature. Nonlimiting examples of fibers include wood pulp fibers and synthetic staple fibers such as polyester fibers.
Filaments are typically considered continuous or substantially continuous in nature. Filaments are relatively longer than fibers. Nonlimiting examples of filaments include meltblown and/or spunbond filaments. Nonlimiting examples of materials that can be spun into filaments include natural polymers, such as starch, starch derivatives, cellulose and cellulose derivatives, hemicellulose, hemicellulose derivatives, and synthetic polymers including, but not limited to polyvinyl alcohol filaments and/or polyvinyl alcohol derivative filaments, and thermoplastic polymer filaments, such as polyesters, nylons, polyolefins such as polypropylene filaments, polyethylene filaments, and biodegradable or compostable thermoplastic fibers such as polylactic acid filaments, polyhydroxyalkanoate filaments and polycaprolactone filaments. The filaments may be monocomponent or multicomponent, such as bicomponent filaments.
In one example of the present invention, “fiber” refers to papermaking fibers. Papermaking fibers useful in the present invention include cellulosic fibers commonly known as wood pulp fibers. Applicable wood pulps include chemical pulps, such as Kraft, sulfite, and sulfate pulps, as well as mechanical pulps including, for example, groundwood, thermomechanical pulp and chemically modified thermomechanical pulp. Chemical pulps, however, may be preferred since they impart a superior tactile sense of softness to tissue sheets made therefrom. Pulps derived from both deciduous trees (hereinafter, also referred to as “hardwood”) and coniferous trees (hereinafter, also referred to as “softwood”) may be utilized. The hardwood and softwood fibers can be blended, or alternatively, can be deposited in layers to provide a stratified web. U.S. Pat. Nos. 4,300,981; 3,994,771 are incorporated herein by reference for the purpose of disclosing layering of hardwood and softwood fibers. Also applicable to the present invention are fibers derived from recycled paper, which may contain any or all of the above categories as well as other non-fibrous materials such as fillers and adhesives used to facilitate the original papermaking.
In addition to the various wood pulp fibers, other cellulosic fibers such as cotton linters, rayon, lyocell and bagasse can be used in this invention. Other sources of cellulose in the form of fibers or capable of being spun into fibers include grasses and grain sources.
“Sanitary tissue product” as used herein means a soft, low density (i.e. <about 0.15 g/cm3) web useful as a wiping implement for post-urinary and post-bowel movement cleaning (toilet tissue), for otorhinolaryngological discharges (facial tissue), and multi-functional absorbent and cleaning uses (absorbent towels). The sanitary tissue product may be convolutedly wound upon itself about a core or without a core to form a sanitary tissue product roll.
In one example, the sanitary tissue product of the present invention comprises a fibrous structure according to the present invention.
The sanitary tissue products of the present invention may exhibit a basis weight between about 10 g/m2 to about 120 g/m2 and/or from about 15 g/m2 to about 110 g/m2 and/or from about 20 g/m2 to about 100 g/m2 and/or from about 30 to 90 g/m2. In addition, the sanitary tissue product of the present invention may exhibit a basis weight between about 40 g/m2 to about 120 g/m2 and/or from about 50 g/m2 to about 110 g/m2 and/or from about 55 g/m2 to about 105 g/m2 and/or from about 60 to 100 g/m2.
The sanitary tissue products of the present invention may exhibit a total dry tensile strength of greater than about 59 g/cm (150 g/in) and/or from about 78 g/cm (200 g/in) to about 394 g/cm (1000 g/in) and/or from about 98 g/cm (250 g/in) to about 335 g/cm (850 g/in). In addition, the sanitary tissue product of the present invention may exhibit a total dry tensile strength of greater than about 196 g/cm (500 g/in) and/or from about 196 g/cm (500 g/in) to about 394 g/cm (1000 g/in) and/or from about 216 g/cm (550 g/in) to about 335 g/cm (850 g/in) and/or from about 236 g/cm (600 g/in) to about 315 g/cm (800 g/in). In one example, the sanitary tissue product exhibits a total dry tensile strength of less than about 394 g/cm (1000 g/in) and/or less than about 335 g/cm (850 g/in).
In another example, the sanitary tissue products of the present invention may exhibit a total dry tensile strength of greater than about 196 g/cm (500 g/in) and/or greater than about 236 g/cm (600 g/in) and/or greater than about 276 g/cm (700 g/in) and/or greater than about 315 g/cm (800 g/in) and/or greater than about 354 g/cm (900 g/in) and/or greater than about 394 g/cm (1000 g/in) and/or from about 315 g/cm (800 g/in) to about 1968 g/cm (5000 g/in) and/or from about 354 g/cm (900 g/in) to about 1181 g/cm (3000 g/in) and/or from about 354 g/cm (900 g/in) to about 984 g/cm (2500 g/in) and/or from about 394 g/cm (1000 g/in) to about 787 g/cm (2000 g/in).
The sanitary tissue products of the present invention may exhibit an initial total wet tensile strength of less than about 78 g/cm (200 g/in) and/or less than about 59 g/cm (150 g/in) and/or less than about 39 g/cm (100 g/in) and/or less than about 29 g/cm (75 g/in).
The sanitary tissue products of the present invention may exhibit an initial total wet tensile strength of greater than about 118 g/cm (300 g/in) and/or greater than about 157 g/cm (400 g/in) and/or greater than about 196 g/cm (500 g/in) and/or greater than about 236 g/cm (600 g/in) and/or greater than about 276 g/cm (700 g/in) and/or greater than about 315 g/cm (800 g/in) and/or greater than about 354 g/cm (900 g/in) and/or greater than about 394 g/cm (1000 g/in) and/or from about 118 g/cm (300 g/in) to about 1968 g/cm (5000 g/in) and/or from about 157 g/cm (400 g/in) to about 1181 g/cm (3000 g/in) and/or from about 196 g/cm (500 g/in) to about 984 g/cm (2500 g/in) and/or from about 196 g/cm (500 g/in) to about 787 g/cm (2000 g/in) and/or from about 196 g/cm (500 g/in) to about 591 g/cm (1500 g/in).
The sanitary tissue products of the present invention may exhibit a density (measured at 95 g/in2) of less than about 0.60 g/cm3 and/or less than about 0.30 g/cm3 and/or less than about 0.20 g/cm3 and/or less than about 0.10 g/cm3 and/or less than about 0.07 g/cm3 and/or less than about 0.05 g/cm3 and/or from about 0.01 g/cm3 to about 0.20 g/cm3 and/or from about 0.02 g/cm3 to about 0.10 g/cm3.
The sanitary tissue products of the present invention may exhibit a total absorptive capacity of according to the Horizontal Full Sheet (HFS) Test Method described herein of greater than about 10 g/g and/or greater than about 12 g/g and/or greater than about 15 g/g and/or from about 15 g/g to about 50 g/g and/or to about 40 g/g and/or to about 30 g/g.
The sanitary tissue products of the present invention may exhibit a Vertical Full Sheet (VFS) value as determined by the Vertical Full Sheet (VFS) Test Method described herein of greater than about 5 g/g and/or greater than about 7 g/g and/or greater than about 9 g/g and/or from about 9 g/g to about 30 g/g and/or to about 25 g/g and/or to about 20 g/g and/or to about 17 g/g.
The sanitary tissue products of the present invention may be in the form of sanitary tissue product rolls. Such sanitary tissue product rolls may comprise a plurality of connected, but perforated sheets of fibrous structure, that are separably dispensable from adjacent sheets. In one example, one or more ends of the roll of sanitary tissue product may comprise an adhesive and/or dry strength agent to mitigate the loss of fibers, especially wood pulp fibers from the ends of the roll of sanitary tissue product.
The sanitary tissue products of the present invention may comprises additives such as softening agents, temporary wet strength agents, permanent wet strength agents, bulk softening agents, lotions, silicones, wetting agents, latexes, especially surface-pattern-applied latexes, dry strength agents such as carboxymethylcellulose and starch, and other types of additives suitable for inclusion in and/or on sanitary tissue products.
“Weight average molecular weight” as used herein means the weight average molecular weight as determined using gel permeation chromatography according to the protocol found in Colloids and Surfaces A. Physico Chemical & Engineering Aspects, Vol. 162, 2000, pg. 107-121.
“Basis Weight” as used herein is the weight per unit area of a sample reported in lbs/3000 ft2 or g/m2.
“Machine Direction” or “MD” as used herein means the direction parallel to the flow of the fibrous structure through the fibrous structure making machine and/or sanitary tissue product manufacturing equipment.
“Cross Machine Direction” or “CD” as used herein means the direction parallel to the width of the fibrous structure making machine and/or sanitary tissue product manufacturing equipment and perpendicular to the machine direction.
“Ply” as used herein means an individual, integral fibrous structure.
“Plies” as used herein means two or more individual, integral fibrous structures disposed in a substantially contiguous, face-to-face relationship with one another, forming a multi-ply fibrous structure and/or multi-ply sanitary tissue product. It is also contemplated that an individual, integral fibrous structure can effectively form a multi-ply fibrous structure, for example, by being folded on itself.
“Total Pore Volume” as used herein means the sum of the fluid holding void volume in each pore range from 1 μm to 1000 μm radii as measured according to the Pore Volume Test Method described herein.
“Pore Volume Distribution” as used herein means the distribution of fluid holding void volume as a function of pore radius. The Pore Volume Distribution of a fibrous structure is measured according to the Pore Volume Test Method described herein.
As used herein, the articles “a” and “an” when used herein, for example, “an anionic surfactant” or “a fiber” is understood to mean one or more of the material that is claimed or described.
All percentages and ratios are calculated by weight unless otherwise indicated. All percentages and ratios are calculated based on the total composition unless otherwise indicated.
Unless otherwise noted, all component or composition levels are in reference to the active level of that component or composition, and are exclusive of impurities, for example, residual solvents or by-products, which may be present in commercially available sources.
Fibrous Structure
It has surprisingly been found that the fibrous structures of the present invention exhibit a pore volume distribution unlike pore volume distributions of other known fibrous structures.
The fibrous structures of the present invention may comprise a plurality of filaments, a plurality of solid additives, such as fibers, and a mixture of filaments and solid additives.
As shown in
Such fibrous structures have been found to exhibit consumer-recognizable beneficial absorbent capacity. In one example, the fibrous structures comprise a plurality of solid additives, for example fibers. In another example, the fibrous structures comprise a plurality of filaments. In yet another example, the fibrous structures comprise a mixture of filaments and solid additives, such as fibers.
As shown in
A fibrous structure according to the present invention exhibiting a bi-modal pore volume distribution as described above provides beneficial absorbent capacity and absorbent rate as a result of the larger radii pores and beneficial surface drying as a result of the smaller radii pores.
As shown in
Further, the layered fibrous structure 10′ may comprise a third layer 22, as shown in
As shown in
In another example of a fibrous structure in accordance with the present invention, instead of being layers of fibrous structure 10″, the material forming layers 26, 28 and 30, may be in the form of plies wherein two or more of the plies may be combined to form a fibrous structure. The plies may be bonded together, such as by thermal bonding and/or adhesive bonding, to form a multi-ply fibrous structure.
Another example of a fibrous structure of the present invention in accordance with the present invention is shown in
Two or more of the plies 36, 38 and 42 may be bonded together, such as by thermal bonding and/or adhesive bonding, to form a multi-ply fibrous structure. After a bonding operation, especially a thermal bonding operation, it may be difficult to distinguish the plies of the fibrous structure 10′″ and the fibrous structure 10′″ may visually and/or physically be a similar to a layered fibrous structure in that one would have difficulty separating the once individual plies from each other. In one example, ply 36 may comprise a fibrous structure that exhibits a basis weight of at least about 15 g/m2 and/or at least about 20 g/m2 and/or at least about 25 g/m2 and/or at least about 30 g/m2 up to about 120 g/m2 and/or 100 g/m2 and/or 80 g/m2 and/or 60 g/m2 and the plies 38 and 42, when present, independently and individually, may comprise fibrous structures that exhibit basis weights of less than about 10 g/m2 and/or less than about 7 g/m2 and/or less than about 5 g/m2 and/or less than about 3 g/m2 and/or less than about 2 g/m2 and/or to about 0 g/m2 and/or 0.5 g/m2.
Plies 38 and 42, when present, may help retain the solid additives, in this case the wood pulp fibers 14, on and/or within the fibrous structure of ply 36 thus reducing lint and/or dust (as compared to a single-ply fibrous structure comprising the fibrous structure of ply 36 without the plies 38 and 42) resulting from the wood pulp fibers 14 becoming free from the fibrous structure of ply 36.
The fibrous structures of the present invention may comprise any suitable amount of filaments and any suitable amount of solid additives. For example, the fibrous structures may comprise from about 10% to about 70% and/or from about 20% to about 60% and/or from about 30% to about 50% by dry weight of the fibrous structure of filaments and from about 90% to about 30% and/or from about 80% to about 40% and/or from about 70% to about 50% by dry weight of the fibrous structure of solid additives, such as wood pulp fibers.
The filaments and solid additives of the present invention may be present in fibrous structures according to the present invention at weight ratios of filaments to solid additives of from at least about 1:1 and/or at least about 1:1.5 and/or at least about 1:2 and/or at least about 1:2.5 and/or at least about 1:3 and/or at least about 1:4 and/or at least about 1:5 and/or at least about 1:7 and/or at least about 1:10.
The fibrous structures of the present invention and/or any sanitary tissue products comprising such fibrous structures may be subjected to any post-processing operations such as embossing operations, printing operations, tuft-generating operations, thermal bonding operations, ultrasonic bonding operations, perforating operations, surface treatment operations such as application of lotions, silicones and/or other materials and mixtures thereof.
Any hydrophobic or non-hydrophilic materials within the fibrous structure, such as polypropylene filaments, may be surface treated and/or melt treated with a hydrophilic modifier. Nonlimiting examples of surface treating hydrophilic modifiers include surfactants, such as Triton X-100. Nonlimiting examples of melt treating hydrophilic modifiers that are added to the melt, such as the polypropylene melt, prior to spinning filaments, include hydrophilic modifying melt additives such as VW351 commercially available from Polyvel, Inc. and Irgasurf commercially available from Ciba. The hydrophilic modifier may be associated with the hydrophobic or non-hydrophilic material at any suitable level known in the art. In one example, the hydrophilic modifier is associated with the hydrophobic or non-hydrophilic material at a level of less than about 20% and/or less than about 15% and/or less than about 10% and/or less than about 5% and/or less than about 3% to about 0% by dry weight of the hydrophobic or non-hydrophilic material.
The fibrous structures of the present invention may include optional additives, each, when present, at individual levels of from about 0% and/or from about 0.01% and/or from about 0.1% and/or from about 1% and/or from about 2% to about 95% and/or to about 80% and/or to about 50% and/or to about 30% and/or to about 20% by dry weight of the fibrous structure. Nonlimiting examples of optional additives include permanent wet strength agents, temporary wet strength agents, dry strength agents such as carboxymethylcellulose and/or starch, softening agents, lint reducing agents, opacity increasing agents, wetting agents, odor absorbing agents, perfumes, temperature indicating agents, color agents, dyes, osmotic materials, microbial growth detection agents, antibacterial agents and mixtures thereof.
The fibrous structure of the present invention may itself be a sanitary tissue product. It may be convolutedly wound about a core to form a roll. It may be combined with one or more other fibrous structures as a ply to form a multi-ply sanitary tissue product. In one example, a co-formed fibrous structure of the present invention may be convolutedly wound about a core to form a roll of co-formed sanitary tissue product. The rolls of sanitary tissue products may also be coreless.
As shown in
The bond region 52 may comprise a bonding agent selected from chemical agents and/or mechanical agents. Nonlimiting examples of chemical agents include dry strength agents and wet strength agents and mixtures thereof. The mechanical agents may be in the form of a liquid and/or a solid. A liquid mechanical agent may be an oil. A solid mechanical agent may be a wax.
The bond region 52 may comprise different types of bonding agents and/or bonding agents that are chemically different from the filaments and/or fibers present in the fibrous structure. In one example, the material comprises a bonding agent, such as a dry strength resin such as a polysaccharide and/or a polysaccharide derivative and temporary and permanent wet strength resins. Nonlimiting examples of suitable bonding agents include latex dispersions, polyvinyl alcohol, Parez®, Kymene®, carboxymethylcellulose and starch.
As shown in
To further illustrate the fibrous structures of the present invention, Table 1 sets forth the average pore volume distributions of known and/or commercially available fibrous structures and a fibrous structure in accordance with the present invention.
The fibrous structures of the present invention may exhibit a unique combination of fibrous structure properties that do not exist in known fibrous structures. For example, the fibrous structures may exhibit a VFS of greater than about 11 g/g and/or greater than about 12 g/g and/or greater than about 13 g/g and/or greater than about 14 g/g and/or less than about 50 g/g and/or less than about 40 g/g and/or less than about 30 g/g and/or less than about 20 g/g and/or from about 11 g/g to about 50 g/g and/or from about 11 g/g to about 40 g/g and/or from about 11 g/g to about 30 g/g and/or from about 11 g/g to about 20 g/g.
In addition to the VFS property, the fibrous structures of the present invention may exhibit a Dry CD Tensile Modulus of less than about 1500 g/cm and/or less than about 1400 g/cm and/or less than about 1300 g/cm and/or less than about 1100 g/cm and/or less than about 1000 g/cm and/or less than about 800 g/cm and/or greater than about 50 g/cm and/or greater than about 100 g/cm and/or greater than about 300 g/cm and/or from about 50 g/cm to about 1500 g/cm and/or from about 100 g/cm to about 1400 g/cm and/or from about 100 g/cm to about 1300 g/cm.
In addition to the VFS property and/or the Dry CD Tensile Modulus property, the fibrous structures of the present invention may exhibit a Wet CD TEA of greater than about 35 (g·in)/in2 and/or greater than about 50 (g·in)/in2 and/or greater than about 75 (g·in)/in2 and/or greater than about 90 (g·in)/in2 and/or greater than about 150 (g·in)/in2 and/or greater than about 175 (g·in)/in2 and/or less than about 500 (g·in)/in2 and/or less than about 400 (g·in)/in2 and/or less than about 350 (g·in)/in2 and/or less than about 300 (g·in)/in2 and/or from about 35 (g·in)/in2 to about 500 (g·in)/in2 and/or from about 35 (g·in)/in2 to about 400 (g·in)/in2 and/or from about 50 (g·in)/in2 to about 350 (g·in)/in2 and/or from about 75 (g·in)/in2 to about 300 (g·in)/in2.
In addition to the VFS property and/or the Dry CD Tensile Modulus property and/or the Wet CD TEA, the fibrous structures of the present invention may exhibit a Wet MD TEA of greater than about 40 (g·in)/in2 and/or greater than about 50 (g·in)/in2 and/or greater than about 75 (g·in)/in2 and/or greater than about 90 (g·in)/in2 and/or greater than about 150 (g·in)/in2 and/or greater than about 175 (g·in)/in2 and/or less than about 500 (g·in)/in2 and/or less than about 400 (g·in)/in2 and/or less than about 350 (g·in)/in2 and/or less than about 300 (g·in)/in2 and/or from about 40 (g·in)/in2 to about 500 (g·in)/in2 and/or from about 35 (g·in)/in2 to about 400 (g·in)/in2 and/or from about 50 (g·in)/in2 to about 350 (g·in)/in2 and/or from about 75 (g·in)/in2 to about 300 (g·in)/in2.
In one example of the fibrous structures of the present invention, the fibrous structure exhibits a VFS of greater than about 11 g/g and one or more of the following: a Dry CD Tensile Modulus of less than about 1500 g/cm and/or a Wet CD TEA of greater than about 35 (g·in)/in2 and/or a Wet MD TEA of greater than about 40 (g·in)/in2.
The values of these properties associated with a fibrous structure are determined according to the respective test methods described herein.
To further illustrate the fibrous structures of the present invention, Table 2 sets forth certain properties of known and commercially available fibrous structures and a fibrous structure in accordance with the present invention.
Process For Making A Fibrous Structure
A nonlimiting example of a process for making a fibrous structure according to the present invention is represented in
In one example of the present invention, the fibrous structures are made using a die comprising at least one filament-forming hole, and/or 2 or more and/or 3 or more rows of filament-forming holes from which filaments are spun. At least one row of holes contains 2 or more and/or 3 or more and/or 10 or more filament-forming holes. In addition to the filament-forming holes, the die comprises fluid-releasing holes, such as gas-releasing holes, in one example air-releasing holes, that provide attenuation to the filaments formed from the filament-forming holes. One or more fluid-releasing holes may be associated with a filament-forming hole such that the fluid exiting the fluid-releasing hole is parallel or substantially parallel (rather than angled like a knife-edge die) to an exterior surface of a filament exiting the filament-forming hole. In one example, the fluid exiting the fluid-releasing hole contacts the exterior surface of a filament formed from a filament-forming hole at an angle of less than 30° and/or less than 20° and/or less than 10° and/or less than 5° and/or about 0°. One or more fluid releasing holes may be arranged around a filament-forming hole. In one example, one or more fluid-releasing holes are associated with a single filament-forming hole such that the fluid exiting the one or more fluid releasing holes contacts the exterior surface of a single filament formed from the single filament-forming hole. In one example, the fluid-releasing hole permits a fluid, such as a gas, for example air, to contact the exterior surface of a filament formed from a filament-forming hole rather than contacting an inner surface of a filament, such as what happens when a hollow filament is formed.
In one example, the die comprises a filament-forming hole positioned within a fluid-releasing hole. The fluid-releasing hole 74 may be concentrically or substantially concentrically positioned around a filament-forming hole 76 such as is shown in
In another example, the die comprises filament-forming holes and fluid-releasing holes arranged to produce a plurality of filaments that exhibit a broader range of filament diameters than known filament-forming hole dies, such as knife-edge dies. For example, as shown in
After the fibrous structure 72 has been formed on the collection device, the fibrous structure 72 may be subjected to post-processing operations such as embossing, thermal bonding, tuft-generating operations, moisture-imparting operations, and surface treating operations to form a finished fibrous structure. One example of a surface treating operation that the fibrous structure may be subjected to is the surface application of an elastomeric binder, such as ethylene vinyl acetate (EVA), latexes, and other elastomeric binders. Such an elastomeric binder may aid in reducing the lint created from the fibrous structure during use by consumers. The elastomeric binder may be applied to one or more surfaces of the fibrous structure in a pattern, especially a non-random repeating pattern, or in a manner that covers or substantially covers the entire surface(s) of the fibrous structure.
In one example, the fibrous structure 72 and/or the finished fibrous structure may be combined with one or more other fibrous structures. For example, another fibrous structure, such as a filament-containing fibrous structure, such as a polypropylene filament fibrous structure may be associated with a surface of the fibrous structure 72 and/or the finished fibrous structure. The polypropylene filament fibrous structure may be formed by meltblowing polypropylene filaments (filaments that comprise a second polymer that may be the same or different from the polymer of the filaments in the fibrous structure 72) onto a surface of the fibrous structure 72 and/or finished fibrous structure. In another example, the polypropylene filament fibrous structure may be formed by meltblowing filaments comprising a second polymer that may be the same or different from the polymer of the filaments in the fibrous structure 72 onto a collection device to form the polypropylene filament fibrous structure. The polypropylene filament fibrous structure may then be combined with the fibrous structure 72 or the finished fibrous structure to make a two-ply fibrous structure—three-ply if the fibrous structure 72 or the finished fibrous structure is positioned between two plies of the polypropylene filament fibrous structure like that shown in
In yet another example, the fibrous structure 72 and/or finished fibrous structure may be combined with a filament-containing fibrous structure such that the filament-containing fibrous structure, such as a polysaccharide filament fibrous structure, such as a starch filament fibrous structure, is positioned between two fibrous structures 72 or two finished fibrous structures like that shown in
The process for making fibrous structure 72 may be close coupled (where the fibrous structure is convolutedly wound into a roll prior to proceeding to a converting operation) or directly coupled (where the fibrous structure is not convolutedly wound into a roll prior to proceeding to a converting operation) with a converting operation to emboss, print, deform, surface treat, or other post-forming operation known to those in the art. For purposes of the present invention, direct coupling means that the fibrous structure 72 can proceed directly into a converting operation rather than, for example, being convolutedly wound into a roll and then unwound to proceed through a converting operation.
The process of the present invention may include preparing individual rolls of fibrous structure and/or sanitary tissue product comprising such fibrous structure(s) that are suitable for consumer use. The fibrous structure may be contacted by a bonding agent (such as an adhesive and/or dry strength agent), such that the ends of a roll of sanitary tissue product according to the present invention comprise such adhesive and/or dry strength agent.
The process may further comprise contacting an end edge of a roll of fibrous structure with a material that is chemically different from the filaments and fibers, to create bond regions that bond the fibers present at the end edge and reduce lint production during use. The material may be applied by any suitable process known in the art. Nonlimiting examples of suitable processes for applying the material include non-contact applications, such as spraying, and contact applications, such as gravure roll printing, extruding, surface transferring. In addition, the application of the material may occur by transfer from contact of a log saw and/or perforating blade containing the material since, for example, the perforating operation, an edge of the fibrous structure that may produce lint upon dispensing a fibrous structure sheet from an adjacent fibrous structure sheet may be created.
Nonlimiting Example of Process for Making a Fibrous Structure of the Present Invention:
A 47.5% :47.5%:5% blend of Exxon-Mobil PP3546 polypropylene:Sunoco CP200VM polypropylene:Polyvel S-1416 wetting agent is dry blended, to form a melt blend. The melt blend is heated to 475° F. through a melt extruder. A 10″ wide Biax 12 row spinnerette with 192 nozzles per cross-direction inch, commercially available from Biax Fiberfilm Corporation, is utilized. 32 nozzles per cross-direction inch of the 192 nozzles have a 0.018″ inside diameter while the remaining nozzles are solid, i.e. there is no opening in the nozzle. Approximately 0.17 grams per hole per minute (ghm) of the melt blend is extruded from the open nozzles to form meltblown filaments from the melt blend. Approximately 200 SCFM of compressed air is heated such that the air exhibits a temperature of 395° F. at the spinnerette. Approximately 175 grams/minute of Koch 4825 semi-treated SSK pulp is defibrillated through a hammermill to form SSK wood pulp fibers (solid additive). 330 SCFM of air at 85-90° F. and 85% relative humidity (RH) is drawn into the hammermill and carries the pulp fibers to a solid additive spreader. The solid additive spreader turns the pulp fibers and distributes the pulp fibers in the cross-direction such that the pulp fibers are injected into the meltblown filaments in a perpendicular fashion through a 2″×10″ cross-direction (CD) slot. A forming box surrounds the area where the meltblown filaments and pulp fibers are commingled. This forming box is designed to reduce the amount of air allowed to enter or escape from this commingling area; however, there is a 2″×12″ opening in the bottom of the forming box designed to permit additional cooling air to enter. A forming vacuum pulls air through a forming fabric thus collecting the commingled meltblown filaments and pulp fibers to form a fibrous structure. The forming vacuum is adjusted until an additional 400 SCFM of room air is drawn into the slot in the forming box. The fibrous structure formed by this process comprises about 75% by dry fibrous structure weight of pulp and about 25% by dry fibrous structure weight of meltblown filaments.
As shown in
Optionally, a meltblown layer of the meltblown filaments can be added to one or both sides of the above formed fibrous structure. This addition of the meltblown layer can help reduce the lint created from the fibrous structure during use by consumers and is preferably performed prior to any thermal bonding operation of the fibrous structure. The meltblown filaments for the exterior layers can be the same or different than the meltblown filaments used on the opposite layer or in the center layer(s).
The fibrous structure may be convolutedly wound to form a roll of fibrous structure. The end edges of the roll of fibrous structure may be contacted with a material to create bond regions.
Test Methods
Unless otherwise indicated, all tests described herein including those described under the Definitions section and the following test methods are conducted on samples that have been conditioned in a conditioned room at a temperature of 73° F.±4° F. (about 23° C.±2.2° C.) and a relative humidity of 50%±10% for 2 hours prior to the test. Samples conditioned as described herein are considered dry samples (such as “dry fibrous structures”) for purposes of this invention. Further, all tests are conducted in such conditioned room.
A. Pore Volume Distribution Test Method
Pore Volume Distribution measurements are made on a TRI/Autoporosimeter (TRI/Princeton Inc. of Princeton, N.J.). The TRI/Autoporosimeter is an automated computer-controlled instrument for measuring pore volume distributions in porous materials (e.g., the volumes of different size pores within the range from 1 to 1000 ⊖μm effective pore radii). Complimentary Automated Instrument Software, Release 2000.1, and Data Treatment Software, Release 2000.1 is used to capture, analyze and output the data. More information on the TRI/Autoporosimeter, its operation and data treatments can be found in The Journal of Colloid and Interface Science 162 (1994), pgs 163-170, incorporated here by reference.
As used in this application, determining Pore Volume Distribution involves recording the increment of liquid that enters a porous material as the surrounding air pressure changes. A sample in the test chamber is exposed to precisely controlled changes in air pressure. The size (radius) of the largest pore able to hold liquid is a function of the air pressure. As the air pressure increases (decreases), different size pore groups drain (absorb) liquid. The pore volume of each group is equal to this amount of liquid, as measured by the instrument at the corresponding pressure. The effective radius of a pore is related to the pressure differential by the following relationship.
Pressure differential=[(2)γ cos Θ]/effective radius
where γ=liquid surface tension, and Θ=contact angle.
Typically pores are thought of in terms such as voids, holes or conduits in a porous material. It is important to note that this method uses the above equation to calculate effective pore radii based on the constants and equipment controlled pressures. The above equation assumes uniform cylindrical pores. Usually, the pores in natural and manufactured porous materials are not perfectly cylindrical, nor all uniform. Therefore, the effective radii reported here may not equate exactly to measurements of void dimensions obtained by other methods such as microscopy. However, these measurements do provide an accepted means to characterize relative differences in void structure between materials.
The equipment operates by changing the test chamber air pressure in user-specified increments, either by decreasing pressure (increasing pore size) to absorb liquid, or increasing pressure (decreasing pore size) to drain liquid. The liquid volume absorbed (drained) at each pressure increment is the cumulative volume for the group of all pores between the preceding pressure setting and the current setting.
In this application of the TRI/Autoporosimeter, the liquid is a 0.2 weight % solution of octylphenoxy polyethoxy ethanol (Triton X-100 from Union Carbide Chemical and Plastics Co. of Danbury, Conn.) in distilled water. The instrument calculation constants are as follows: ρ (density)=1 g/cm3; γ (surface tension)=31 dynes/cm; cos Θ=1. A 0.22 μm Millipore Glass Filter (Millipore Corporation of Bedford, Mass.; Catalog #GSWP09025) is employed on the test chamber's porous plate. A plexiglass plate weighing about 24 g (supplied with the instrument) is placed on the sample to ensure the sample rests flat on the Millipore Filter. No additional weight is placed on the sample.
The remaining user specified inputs are described below. The sequence of pore sizes (pressures) for this application is as follows (effective pore radius in μm): 1, 2.5, 5, 10, 15, 20, 30, 40, 50, 60, 70, 80, 90, 100, 120, 140, 160, 180, 200, 225, 250, 275, 300, 350, 400, 500, 600, 800, 1000. This sequence starts with the sample dry, saturates it as the pore settings increase (typically referred to with respect to the procedure and instrument as the 1st absorption).
In addition to the test materials, a blank condition (no sample between plexiglass plate and Millipore Filter) is run to account for any surface and/or edge effects within the chamber. Any pore volume measured for this blank run is subtracted from the applicable pore grouping of the test sample. This data treatment can be accomplished manually or with the available TRI/Autoporosimeter Data Treatment Software, Release 2000.1.
Percent (%) Total Pore Volume is a percentage calculated by taking the volume of fluid in the specific pore radii range divided by the Total Pore Volume. The TRI/Autoporosimeter outputs the volume of fluid within a range of pore radii. The first data obtained is for the “2.5 micron” pore radii which includes fluid absorbed between the pore sizes of 1 to 2.5 micron radius. The next data obtained is for “5 micron” pore radii, which includes fluid absorbed between the 2.5 micron and 5 micron radii, and so on. Following this logic, to obtain the volume held within the range of 101-200 micron radii, one would sum the volumes obtained in the range titled “120 micron”, “140 micron”, “160 micron”, “180 micron”, and finally the “200 micron” pore radii ranges. For example, % Total Pore Volume 101-200 micron pore radii=(volume of fluid between 101-200 micron pore radii)/Total Pore Volume
B. Horizontal Full Sheet (HFS) Test Method
The Horizontal Full Sheet (HFS) test method determines the amount of distilled water absorbed and retained by a fibrous structure of the present invention. This method is performed by first weighing a sample of the fibrous structure to be tested (referred to herein as the “dry weight of the sample”), then thoroughly wetting the sample, draining the wetted sample in a horizontal position and then reweighing (referred to herein as “wet weight of the sample”). The absorptive capacity of the sample is then computed as the amount of water retained in units of grams of water absorbed by the sample. When evaluating different fibrous structure samples, the same size of fibrous structure is used for all samples tested.
The apparatus for determining the HFS capacity of fibrous structures comprises the following:
1) An electronic balance with a sensitivity of at least ±0.01 grams and a minimum capacity of 1200 grams. The balance should be positioned on a balance table and slab to minimize the vibration effects of floor/benchtop weighing. The balance should also have a special balance pan to be able to handle the size of the sample tested (i.e.; a fibrous structure sample of about 11 in. (27.9 cm) by 11 in. (27.9 cm)). The balance pan can be made out of a variety of materials. Plexiglass is a common material used.
2) A sample support rack (
The HFS test is performed in an environment maintained at 23±1° C. and 50±2% relative humidity. A water reservoir or tub is filled with distilled water at 23±1° C. to a depth of 3 inches (7.6 cm).
Eight samples of a fibrous structure to be tested are carefully weighed on the balance to the nearest 0.01 grams. The dry weight of each sample is reported to the nearest 0.01 grams. The empty sample support rack is placed on the balance with the special balance pan described above. The balance is then zeroed (tared). One sample is carefully placed on the sample support rack. The support rack cover is placed on top of the support rack. The sample (now sandwiched between the rack and cover) is submerged in the water reservoir. After the sample is submerged for 60 seconds, the sample support rack and cover are gently raised out of the reservoir.
The sample, support rack and cover are allowed to drain horizontally for 120±5 seconds, taking care not to excessively shake or vibrate the sample. While the sample is draining, the rack cover is carefully removed and all excess water is wiped from the support rack. The wet sample and the support rack are weighed on the previously tared balance. The weight is recorded to the nearest 0.01 g. This is the wet weight of the sample.
The gram per fibrous structure sample absorptive capacity of the sample is defined as (wet weight of the sample−dry weight of the sample). The horizontal absorbent capacity (HAC) is defined as: absorbent capacity=(wet weight of the sample−dry weight of the sample)/(dry weight of the sample) and has a unit of gram/gram.
C. Vertical Full Sheet (VFS) Test Method
The Vertical Full Sheet (VFS) test method determines the amount of distilled water absorbed and retained by a fibrous structure of the present invention. This method is performed by first weighing a sample of the fibrous structure to be tested (referred to herein as the “dry weight of the sample”), then thoroughly wetting the sample, draining the wetted sample in a vertical position and then reweighing (referred to herein as “wet weight of the sample”). The absorptive capacity of the sample is then computed as the amount of water retained in units of grams of water absorbed by the sample. When evaluating different fibrous structure samples, the same size of fibrous structure is used for all samples tested.
The apparatus for determining the VFS capacity of fibrous structures comprises the following:
1) An electronic balance with a sensitivity of at least ±0.01 grams and a minimum capacity of 1200 grams. The balance should be positioned on a balance table and slab to minimize the vibration effects of floor/benchtop weighing. The balance should also have a special balance pan to be able to handle the size of the sample tested (i.e.; a fibrous structure sample of about 11 in. (27.9 cm) by 11 in. (27.9 cm)). The balance pan can be made out of a variety of materials. Plexiglass is a common material used.
2) A sample support rack (
The VFS test is performed in an environment maintained at 23±1° C. and 50±2% relative humidity. A water reservoir or tub is filled with distilled water at 23±1° C. to a depth of 3 inches (7.6 cm).
Eight 19.05 cm (7.5 inch)×19.05 cm (7.5 inch) to 27.94 cm (11 inch)×27.94 cm (11 inch) samples of a fibrous structure to be tested are carefully weighed on the balance to the nearest 0.01 grams. The dry weight of each sample is reported to the nearest 0.01 grams. The empty sample support rack is placed on the balance with the special balance pan described above. The balance is then zeroed (tared). One sample is carefully placed on the sample support rack. The support rack cover is placed on top of the support rack. The sample (now sandwiched between the rack and cover) is submerged in the water reservoir. After the sample is submerged for 60 seconds, the sample support rack and cover are gently raised out of the reservoir.
The sample, support rack and cover are allowed to drain vertically for 60±5 seconds, taking care not to excessively shake or vibrate the sample. While the sample is draining, the rack cover is carefully removed and all excess water is wiped from the support rack. The wet sample and the support rack are weighed on the previously tared balance. The weight is recorded to the nearest 0.01 g. This is the wet weight of the sample.
The procedure is repeated for with another sample of the fibrous structure, however, the sample is positioned on the support rack such that the sample is rotated 90° compared to the position of the first sample on the support rack.
The gram per fibrous structure sample absorptive capacity of the sample is defined as (wet weight of the sample−dry weight of the sample). The calculated VFS is the average of the absorptive capacities of the two samples of the fibrous structure.
D. Wet MD TEA, Wet CD TEA, Dry CD Tensile Modulus (“Tangent Modulus”) Test Methods
The Wet MD TEA, Wet CD TEA and Dry CD Tensile Modulus of a fibrous structure are all determined using a Thwing Albert EJA Tensile Tester. A 2.54 cm (1 inch) wide strip of the fibrous structure to be tested is placed in the grips of the Tensile Tester at a gauge length of 10.16 cm (4 inches). The Crosshead Speed of the Tensile Tester is set at 10.16 cm/min (4 inches/min) and the Break Sensitivity is set at 20 g. Eight (8) samples are run on the Tensile Tester and an average of the respective Wet MD TEA, Wet CD TEA values from the 8 samples is reported as the Wet MD TEA value and the Wet CD TEA. The Dry CD Tensile Modulus is reported as the average of the Dry CD Tensile Modulus from the 8 samples measured at 15 g/cm.
E. Basis Weight Test Method
Basis weight is measured by preparing one or more samples of a certain area (m2) and weighing the sample(s) of a fibrous structure according to the present invention and/or a paper product comprising such fibrous structure on a top loading balance with a minimum resolution of 0.01 g. The balance is protected from air drafts and other disturbances using a draft shield. Weights are recorded when the readings on the balance become constant. The average weight (g) is calculated and the average area of the samples (m2). The basis weight (g/m2) is calculated by dividing the average weight (g) by the average area of the samples (m2).
The dimensions and values disclosed herein are not to be understood as being strictly limited to the exact numerical values recited. Instead, unless otherwise specified, each such dimension is intended to mean both the recited value and a functionally equivalent range surrounding that value. For example, a dimension disclosed as “40 mm” is intended to mean “about 40 mm.”
All documents cited in the Detailed Description of the Invention are, in relevant part, incorporated herein by reference; the citation of any document is not to be construed as an admission that it is prior art with respect to the present invention. To the extent that any meaning or definition of a term in this document conflicts with any meaning or definition of the same term in a document incorporated by reference, the meaning or definition assigned to that term in this document shall govern.
While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.
Number | Name | Date | Kind |
---|---|---|---|
2008031 | Miller | Jul 1931 | A |
2175045 | Vogel | Oct 1939 | A |
3521638 | Parrish | Jul 1970 | A |
3838692 | Levesque | Oct 1974 | A |
3954361 | Page | May 1976 | A |
4100324 | Anderson et al. | Jul 1978 | A |
4118531 | Hauser | Oct 1978 | A |
4139699 | Hernandez et al. | Feb 1979 | A |
4203939 | Drachenberg et al. | May 1980 | A |
4243480 | Hernandez et al. | Jan 1981 | A |
4270289 | Kimura | Jun 1981 | A |
4295987 | Parks | Oct 1981 | A |
4355066 | Newman | Oct 1982 | A |
4370289 | Sorenson | Jan 1983 | A |
4436780 | Hotchkiss et al. | Mar 1984 | A |
4604313 | McFarland et al. | Aug 1986 | A |
4623576 | Lloyd et al. | Nov 1986 | A |
4634621 | Manning et al. | Jan 1987 | A |
4636418 | Kennard et al. | Jan 1987 | A |
4675226 | Ott | Jun 1987 | A |
4720415 | Vander Wielen et al. | Jan 1988 | A |
4724114 | McFarland et al. | Feb 1988 | A |
4786550 | McFarland et al. | Nov 1988 | A |
4803117 | Daponte | Feb 1989 | A |
4808467 | Suskind et al. | Feb 1989 | A |
4851168 | Graiver et al. | Jul 1989 | A |
4855179 | Bourland et al. | Aug 1989 | A |
4863779 | Daponte | Sep 1989 | A |
4879170 | Radwanski et al. | Nov 1989 | A |
4885202 | Lloyd et al. | Dec 1989 | A |
4906513 | Kebbell et al. | Mar 1990 | A |
4931201 | Julemont | Jun 1990 | A |
4931355 | Radwanski et al. | Jun 1990 | A |
4939016 | Radwanski et al. | Jul 1990 | A |
4950601 | Macdonald et al. | Aug 1990 | A |
4970104 | Radwanski | Nov 1990 | A |
5087506 | Palumbo | Feb 1992 | A |
5094717 | Manning et al. | Mar 1992 | A |
5120642 | Schlossman et al. | Jun 1992 | A |
5120888 | Nohr et al. | Jun 1992 | A |
5144729 | Austin et al. | Sep 1992 | A |
5145727 | Potts et al. | Sep 1992 | A |
5149576 | Potts et al. | Sep 1992 | A |
5160746 | Dodge, II et al. | Nov 1992 | A |
5204165 | Schortmann | Apr 1993 | A |
5227107 | Dickenson et al. | Jul 1993 | A |
5254133 | Seid | Oct 1993 | A |
5254399 | Oku et al. | Oct 1993 | A |
5272236 | Lai et al. | Dec 1993 | A |
5284703 | Everhart et al. | Feb 1994 | A |
5350624 | Georger et al. | Sep 1994 | A |
5375306 | Roussin-Moynier | Dec 1994 | A |
5409768 | Dickenson et al. | Apr 1995 | A |
5427696 | Phan et al. | Jun 1995 | A |
5436066 | Chen | Jul 1995 | A |
5476616 | Schwarz | Dec 1995 | A |
5508102 | Georger et al. | Apr 1996 | A |
5509915 | Hanson et al. | Apr 1996 | A |
5536563 | Shah et al. | Jul 1996 | A |
5539056 | Yang et al. | Jul 1996 | A |
5587225 | Griesbach et al. | Dec 1996 | A |
5597873 | Chambers et al. | Jan 1997 | A |
5611890 | Vinson et al. | Mar 1997 | A |
5629080 | Gupta et al. | May 1997 | A |
5652048 | Haynes et al. | Jul 1997 | A |
5811178 | Adam et al. | Sep 1998 | A |
5814570 | Cohen | Sep 1998 | A |
5834385 | Blaney et al. | Nov 1998 | A |
5853867 | Harada et al. | Dec 1998 | A |
5948710 | Pomplun et al. | Sep 1999 | A |
5952251 | Jackson et al. | Sep 1999 | A |
5962112 | Haynes et al. | Oct 1999 | A |
6013349 | Takeuchi et al. | Jan 2000 | A |
6028018 | Amundson et al. | Feb 2000 | A |
6103061 | Anderson et al. | Aug 2000 | A |
6110848 | Bouchette | Aug 2000 | A |
6150005 | Williams et al. | Nov 2000 | A |
6162180 | Miesel et al. | Dec 2000 | A |
6172276 | Hetzler et al. | Jan 2001 | B1 |
6177370 | Skoog et al. | Jan 2001 | B1 |
6179325 | King | Jan 2001 | B1 |
6200120 | Fish et al. | Mar 2001 | B1 |
6296936 | Yahiaoui et al. | Oct 2001 | B1 |
6319342 | Riddell | Nov 2001 | B1 |
6348133 | Woodrum | Feb 2002 | B1 |
6348253 | Daley et al. | Feb 2002 | B1 |
6361784 | Brennan et al. | Mar 2002 | B1 |
6383336 | Shannon | May 2002 | B1 |
6417120 | Mitchler et al. | Jul 2002 | B1 |
6423884 | Oehmen | Jul 2002 | B1 |
6465073 | Morman et al. | Oct 2002 | B1 |
6488801 | Bodaghi et al. | Dec 2002 | B1 |
6494974 | Riddell | Dec 2002 | B2 |
6503370 | Hollmark et al. | Jan 2003 | B2 |
6506873 | Ryan et al. | Jan 2003 | B1 |
6550115 | Skoog et al. | Apr 2003 | B1 |
6589892 | Smith et al. | Jul 2003 | B1 |
6608236 | Burns et al. | Aug 2003 | B1 |
6621679 | Segervall | Sep 2003 | B1 |
6638884 | Quick et al. | Oct 2003 | B2 |
6686303 | Haynes et al. | Feb 2004 | B1 |
6709526 | Bailey et al. | Mar 2004 | B1 |
6739023 | Vonfeldt et al. | May 2004 | B2 |
6759356 | Myers | Jul 2004 | B1 |
6797226 | Annable | Sep 2004 | B2 |
6811638 | Close et al. | Nov 2004 | B2 |
6823568 | Kobayashi et al. | Nov 2004 | B1 |
6836937 | Boscolo | Jan 2005 | B1 |
6926931 | Qashou et al. | Aug 2005 | B2 |
6946413 | Lange et al. | Sep 2005 | B2 |
6979386 | Wallajapet et al. | Dec 2005 | B1 |
6986932 | Zink et al. | Jan 2006 | B2 |
6992028 | Thomaschefsky et al. | Jan 2006 | B2 |
7029620 | Gordon et al. | Jan 2006 | B2 |
7000000 | O'Brien | Feb 2006 | B1 |
7028429 | Druliner | Apr 2006 | B1 |
7041369 | Mackey | May 2006 | B1 |
7176150 | Kopacz et al. | Feb 2007 | B2 |
7208429 | Vinson et al. | Apr 2007 | B2 |
7371701 | Inagaki | May 2008 | B2 |
7410683 | Curro et al. | Aug 2008 | B2 |
7425517 | Deka et al. | Sep 2008 | B2 |
7524379 | Bailey et al. | Apr 2009 | B2 |
7601657 | Zhou et al. | Oct 2009 | B2 |
7681756 | Baer et al. | Mar 2010 | B2 |
7696109 | Ouellette et al. | Apr 2010 | B2 |
7879172 | Kopcz et al. | Feb 2011 | B2 |
7902096 | Brandner et al. | Mar 2011 | B2 |
7972986 | Barnholtz et al. | Jul 2011 | B2 |
7976679 | Vinson et al. | Jul 2011 | B2 |
7994079 | Chen et al. | Aug 2011 | B2 |
7994081 | Farrell et al. | Aug 2011 | B2 |
7998889 | Stralin et al. | Aug 2011 | B2 |
8017534 | Harvey et al. | Sep 2011 | B2 |
9926648 | Barnholtz et al. | Mar 2018 | B2 |
10024000 | Barnholtz | Jul 2018 | B2 |
10513801 | Barnholtz et al. | Dec 2019 | B2 |
20030024662 | Besemer et al. | Feb 2003 | A1 |
20030060113 | Christie et al. | Mar 2003 | A1 |
20030073367 | Kopacz et al. | Apr 2003 | A1 |
20030106560 | Griesbach et al. | Jun 2003 | A1 |
20030114066 | Clark et al. | Jun 2003 | A1 |
20030116890 | Chambers et al. | Jun 2003 | A1 |
20030131457 | Krautkramer et al. | Jul 2003 | A1 |
20030135172 | Whitmore et al. | Jul 2003 | A1 |
20030150090 | Krautkramer et al. | Aug 2003 | A1 |
20030200991 | Keck et al. | Oct 2003 | A1 |
20030203196 | Trokhan | Oct 2003 | A1 |
20030211802 | Keck et al. | Nov 2003 | A1 |
20030211862 | Keck et al. | Nov 2003 | A1 |
20030220039 | Chen et al. | Nov 2003 | A1 |
20030224686 | Andersen | Dec 2003 | A1 |
20040048542 | Thomaschefsy et al. | Mar 2004 | A1 |
20040065422 | Hu et al. | Apr 2004 | A1 |
20040087237 | Garnier et al. | May 2004 | A1 |
20040096656 | Bond | May 2004 | A1 |
20040106723 | Yang et al. | Jun 2004 | A1 |
20040116018 | Fenwick et al. | Jun 2004 | A1 |
20040123963 | Chen et al. | Jul 2004 | A1 |
20040163781 | Hemandez-Munoa et al. | Aug 2004 | A1 |
20040181199 | Moberg-Alehammar et al. | Sep 2004 | A1 |
20050020170 | Deka et al. | Jan 2005 | A1 |
20050056956 | Zhao et al. | Mar 2005 | A1 |
20050090175 | Bergholm et al. | Apr 2005 | A1 |
20050103455 | Edwards et al. | May 2005 | A1 |
20050112980 | Strandquist et al. | May 2005 | A1 |
20050130536 | Siebers et al. | Jun 2005 | A1 |
20050130544 | Cheng et al. | Jun 2005 | A1 |
20050133177 | Stralin et al. | Jun 2005 | A1 |
20050133971 | Haynes et al. | Jun 2005 | A1 |
20050136765 | Shannon | Jun 2005 | A1 |
20050136772 | Chen et al. | Jun 2005 | A1 |
20050136778 | Thomaschefsky et al. | Jun 2005 | A1 |
20050137540 | Villanueva | Jun 2005 | A1 |
20050148262 | Varona et al. | Jul 2005 | A1 |
20050148264 | Varona | Jul 2005 | A1 |
20050159065 | Stralin et al. | Jul 2005 | A1 |
20050170727 | Mekik et al. | Aug 2005 | A1 |
20050170729 | Stadelman et al. | Aug 2005 | A1 |
20050177122 | Berba et al. | Aug 2005 | A1 |
20050245159 | Chmielewski et al. | Nov 2005 | A1 |
20050247416 | Forry et al. | Nov 2005 | A1 |
20050266760 | Chhabra et al. | Dec 2005 | A1 |
20050274470 | Shannon et al. | Dec 2005 | A1 |
20050279470 | Redd et al. | Dec 2005 | A1 |
20060014460 | Alexander et al. | Jan 2006 | A1 |
20060084340 | Bond et al. | Apr 2006 | A1 |
20060086633 | Kleinsmith | Apr 2006 | A1 |
20060088697 | Manifold et al. | Apr 2006 | A1 |
20060134384 | Vinson et al. | Jun 2006 | A1 |
20060141891 | Melius et al. | Jun 2006 | A1 |
20070010153 | Shaffer et al. | Jan 2007 | A1 |
20070039704 | Cabell et al. | Feb 2007 | A1 |
20070049153 | Dunbar | Mar 2007 | A1 |
20070063091 | Neveu | Mar 2007 | A1 |
20070077841 | Zoch et al. | Apr 2007 | A1 |
20070173162 | Ethiopia et al. | Jul 2007 | A1 |
20070202766 | Ouellette | Aug 2007 | A1 |
20070232180 | Polat et al. | Oct 2007 | A1 |
20070269627 | Vinson et al. | Nov 2007 | A1 |
20070272381 | Elony et al. | Nov 2007 | A1 |
20080000602 | Dyer et al. | Jan 2008 | A1 |
20080008853 | Hupp et al. | Jan 2008 | A1 |
20080041543 | Dyer et al. | Feb 2008 | A1 |
20080050996 | Stralin et al. | Feb 2008 | A1 |
20080051471 | Kronberg et al. | Feb 2008 | A1 |
20080142178 | Haubrich et al. | Jun 2008 | A1 |
20080241538 | Lee et al. | Oct 2008 | A1 |
20080248239 | Pomeroy et al. | Oct 2008 | A1 |
20090022960 | Suer et al. | Jan 2009 | A1 |
20090022983 | Cabell et al. | Jan 2009 | A1 |
20090023839 | Barnholtz et al. | Jan 2009 | A1 |
20090084513 | Barnholtz et al. | Apr 2009 | A1 |
20090093585 | Smith et al. | Apr 2009 | A1 |
20090151748 | Ridenhour | Jun 2009 | A1 |
20090220741 | Manifold et al. | Sep 2009 | A1 |
20090220769 | Manifold et al. | Sep 2009 | A1 |
20100048082 | Topolkaraev et al. | Feb 2010 | A1 |
20100239825 | Sheehan et al. | Sep 2010 | A1 |
20100326612 | Hupp et al. | Dec 2010 | A1 |
20110039054 | Cabell et al. | Feb 2011 | A1 |
20110045261 | Sellars | Feb 2011 | A1 |
20110100574 | Barnholtz et al. | May 2011 | A1 |
20110104419 | Barnholtz et al. | May 2011 | A1 |
20110104444 | Barnholtz et al. | May 2011 | A1 |
20110104493 | Barnholtz et al. | May 2011 | A1 |
20110104970 | Barnholtz et al. | May 2011 | A1 |
20110209840 | Barnholtz et al. | Sep 2011 | A1 |
20110220310 | Polat et al. | Sep 2011 | A1 |
20110244199 | Brennan et al. | Oct 2011 | A1 |
20120318693 | Barnholtz et al. | Dec 2012 | A1 |
20180305871 | Barnholtz et al. | Oct 2018 | A1 |
20190136458 | Barnholtz et al. | May 2019 | A1 |
20200102671 | Barnholtz et al. | Apr 2020 | A1 |
Number | Date | Country |
---|---|---|
199 59 832 | Jul 2001 | DE |
0 080 382 | Nov 1982 | EP |
0 156 649 | Oct 1985 | EP |
1 156 160 | Oct 1985 | EP |
0 294 137 | Dec 1988 | EP |
0 333 209 | Sep 1989 | EP |
0 341 977 | Nov 1989 | EP |
0 205 242 | Dec 1991 | EP |
1 156 147 | Nov 2001 | EP |
1 887 036 | Feb 2008 | EP |
2 028 296 | Feb 2009 | EP |
2113731 | Aug 1983 | GB |
59-211667 | Nov 1984 | JP |
08-174735 | Jul 1996 | JP |
2000303335 | Oct 2000 | JP |
2002088660 | Mar 2002 | JP |
2004-141255 | May 2004 | JP |
2005218525 | Aug 2005 | JP |
WO 9419179 | Sep 1994 | WO |
WO 9855295 | Dec 1998 | WO |
WO 0011998 | Mar 2000 | WO |
WO 0029655 | May 2000 | WO |
WO 0063486 | Oct 2000 | WO |
WO 0109023 | Feb 2001 | WO |
WO 0166345 | Sep 2001 | WO |
WO 03050347 | Jun 2003 | WO |
WO 03080905 | Oct 2003 | WO |
2004098474 | Nov 2004 | WO |
WO 2005073446 | Aug 2005 | WO |
WO 2005080497 | Sep 2005 | WO |
WO 2005106085 | Nov 2005 | WO |
WO 2005118934 | Dec 2005 | WO |
WO 2006027810 | Mar 2006 | WO |
WO 2007070064 | Jun 2007 | WO |
WO 2007070075 | Jun 2007 | WO |
WO 2007078344 | Jul 2007 | WO |
WO 2007098449 | Aug 2007 | WO |
WO 2007100936 | Sep 2007 | WO |
WO 2007124866 | Nov 2007 | WO |
WO 2007135624 | Nov 2007 | WO |
WO 2008005500 | Jan 2008 | WO |
WO 2008050311 | May 2008 | WO |
WO 2009010940 | Jan 2009 | WO |
WO 2009010941 | Jan 2009 | WO |
WO 2009010942 | Jan 2009 | WO |
Entry |
---|
U.S. Appl. No. 16/237,950, filed Jan. 2, 2019, Steven Lee Barnholtz, et al. |
U.S. Appl. No. 16/022,749, filed Jun. 29, 2018, Steven Lee Barnholtz, et al. |
U.S. Appl. No. 15/891,726, filed Feb. 8, 2018, Steven Lee Barnholtz, et al. |
U.S. Appl. No. 12/170,557, filed Jul. 10, 2008, David William Cabell, et al. |
U.S. Appl. No. 12/917,558, filed Nov. 2, 2010, Steven Lee Barnholtz, et al. |
U.S. Appl. No. 12/917,574, filed Nov. 2, 2010, Steven Lee Barnholtz, et al. |
U.S. Appl. No. 12/917,585, filed Nov. 2, 2010, Steven Lee Barnholtz, et al. |
U.S. Appl. No. 13/889,415, filed May 8, 2013, Steven Lee Barnholtz, et al. |
U.S. Appl. No. 14/970,583, filed Dec. 16, 2015, Christopher Michael Young, et al. |
U.S. Appl. No. 14/970,586, filed Dec. 16, 2015, Christopher Michael Young, et al. |
U.S. Appl. No. 14/970,581, filed Dec. 16, 2015, Fei Wang, et al. |
Anonymous, “NanoDispense@ Contact Angle Measurements”, First Ten Angstroms, (Oct. 3, 2004). Retrieved from the Internet: URL: http://www.firsttenangstroms.com/pdfdocs/NanoDispenseExamples.pdf, (retrieved Feb. 15, 2011). Entire document. |
Complete Textile Glossary, Celaneses Acetate (2001), definition of “filament”. |
Meyer, et al., “Comparison between different presentations of pore size distribution in porous materials.” Fresenius J. Anal Chem. 1999. 363: pp. 174-178. |
All Office Actions in U.S. Appl. No. 14/970,581, U.S. Appl. No. 14/970,581, U.S. Appl. No. 14/970,581, U.S. Appl. No. 14/970,581, U.S. Appl. No. 14/970,581, U.S. Appl. No. 14/970,581, U.S. Appl. No. 14/970,581, U.S. Appl. No. 14/970,581, U.S. Appl. No. 14/970,581, U.S. Appl. No. 14/970,581, U.S. Appl. No. 14/970,581, U.S. Appl. No. 14/970,581, U.S. Appl. No. 14/970,581, U.S. Appl. No. 14/970,581, U.S. Appl. No. 14/970,581, U.S. Appl. No. 14/970,581 and U.S. Appl. No. 14/970,581. |
All Office Actions, U.S. Appl. No. 12/170,585. |
All Office Actions, U.S. Appl. No. 16/237,950. |
All Office Actions, U.S. Appl. No. 16/702,920. |
International Search Report and Written Opinion; Application Ser. No.; dated Nov. 18, 2008, 16 pages. |
All Office Actions; U.S. Appl. No. 15/891,726, filed Feb. 8, 2018. |
Miller, Bernard, “Liquid Porosimetry: New Methodology and Applications”Journal of Colloid and Interface Science, Aug. 23, 1993, pp. n163-170. |
Third Party Opposition filed for European Patent Application Ser. No. 08789352.5, Dated Apr. 9, 2018; 14 pages. |
Number | Date | Country | |
---|---|---|---|
20190242066 A1 | Aug 2019 | US |
Number | Date | Country | |
---|---|---|---|
60959813 | Jul 2007 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13106302 | May 2011 | US |
Child | 16237943 | US | |
Parent | 12170585 | Jul 2008 | US |
Child | 13106302 | US |